Cell-free tumour DNA in bronchoalveolar lavage: a proof of concept study

Authors:

Abstract
Extract Molecular analysis is increasingly integral to lung cancer evaluation and management [1]. While evidence of circulating tumor DNA (ctDNA) has existed for decades [2], research in this field centers on ctDNA detection primarily in peripheral blood, which may present limitations. These include reduced sensitivity [3, 4], the potential of false negatives due to low tumor burden or shedding [5], and the possibility that lung compartmentalization may prevent cancer cells from appearing in systematic circulation [6]. We hypothesized that bronchoalveolar lavage (BAL) would exhibit an enrichment of lung cancer-derived cell-free DNA (cfDNA) detectable using digital PCR (dPCR), a precise method for nucleic acid quantification.
Funding Information
  • Juravinski Hospital and Cancer Care Foundation (3576.5024012)
  • Community Health and Education Research Fund of the Hamilton Community Foundation (7738200922)
  • Hamilton Academic Health Sciences Organization (7738200808,)
  • Medical Surgical Association Fund (20018864)

This publication has 13 references indexed in Scilit: